Loading...

Krystal Biotech, Inc.

KRYS•NASDAQ
Healthcare
Biotechnology
$286.95
$20.91(7.86%)
U.S. Market opens in 13h 4m

Krystal Biotech, Inc. (KRYS) Stock Overview

Explore Krystal Biotech, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.4B
P/E Ratio36.32
EPS (TTM)$6.84
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$239.80
3 Months$168.76
1 Year Target$233.83

KRYS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Krystal Biotech, Inc. (KRYS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $233.83.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.32 and a market capitalization of 8.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.85%
5-Day Change
7.94%
1-Month Change
9.60%
3-Month Change
6.61%
6-Month Change
41.16%
Year-to-Date (YTD) Change
16.38%
1-Year Change
76.80%
3-Year Change
249.15%
5-Year Change
290.49%
All-Time (Max) Change
2596.71%

Contact Information

https://www.krystalbio.com
412 586 5830
2100 Wharton Street, Pittsburgh, PA, 15203

Company Facts

275 Employees
IPO DateSep 20, 2017
CountryUS
Actively Trading

Frequently Asked Questions